{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"tesamorelin-stimulants","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-stimulants/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/tesamorelin-stimulants/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-stimulants/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-stimulants/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-stimulants/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-stimulants/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-stimulants/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"tesamorelin-stimulants","title":"Tesamorelin, Semax, Selank, DSIP for Stimulant Load (Adderall/Amphetamine): Evidence-Graded Review","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:42:26.824Z","body_excerpt":"## What's breaking down if you have Stimulant load (Adderall / amphetamine)\n\nAmphetamines force dopamine and norepinephrine release — borrow focus now. Sleep, appetite, and gut lining often suffer — less regeneration window. Chronic load can deplete neurochemistry and stress the gut-brain axis.\n\nDegenerative layers include:\n- Dopamine system: Forced release → depletion → crash, anhedonia, tolerance.\n- Sleep: Stimulants delay sleep onset and cut deep sleep.\n- Gut: Stimulants stress mucosa; gut inflammation affects mood and cognition.\n- Anxiety: Arousal without calm → jitter, rumination, non-restorative stress.\n\nBreakdown outruns repair in these layers when stimulant use continues without sufficient recovery time.\n\n## Why Semax might help you\n\n1. You have **Stimulant load (Adderall / amphetamine)** — breakdown is outpacing repair.\n2. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n\n## Why Selank might help you\n\n1. You have **Stimulant load (Adderall / amphetamine)** — breakdown is outpacing repair.\n2. **Layer breaking down:** Anxiety — Arousal without calm → jitter, rumination, non-restorative stress.\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\n## Why DSIP might help you\n\n1. You have **Stimulant load (Adderall / amphetamine)** — breakdown is outpacing repair.\n2. **Layer breaking down:** Sleep — Stimulants delay sleep onset and cut deep sleep.\n3. **What DSIP is studied to do:** Studied for sleep architecture and deep-sleep promotion.\n4. **Therefore for you:** If that layer is part of your problem, DSIP is discussed because it targets repair (sleep / repair window) — not because it masks pain.\n\n## Why Tesamorelin might help you\n\n1. You have **Stimulant load (Adderall / amphetamine)** — breakdown is outpacing repair.\n2. **Layer breaking down:** GH axis / visceral fat — chronic stimulant effects on metabolism and body composition can compound tissue stress.\n3. **What Tesamorelin is studied to do:** Stimulates pulsatile growth hormone release, studied primarily for reducing visceral adipose tissue while sparing subcutaneous fat.\n4. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain. Human data come from HIV lipodystrophy trials showing VAT reductions; no direct stimulant trials exist.\n\n## Why Amphetamine stimulants matters for you\n\n1. **Drug:** Amphetamine stimulants\n2. **What it does:** Forces neurotransmitter release; borrows focus at cost of sleep/gut reserve.\n3. **Therefore for you:** This drug suppresses a signal (fatigue) and supports metabolism short-term but trades off repair by reducing sleep depth and gut recovery windows. It does not reduce load on neurochemistry or inflammation pathways.\n\n## How these fit together\n\nNeural support (Semax), non-benzo calm (Selank), sleep repair window (DSIP) — each targets a stimulant-degeneration layer.\n- **Semax** → neural / cognitive\n- **Selank** → anxiety / neurochemistry\n- **DSIP** → sleep / repair window\n- **Tesamorelin** → GH axis / visceral fat\n\nThe stack maps distinct layers without overlap: Semax addresses BDNF and cognitive fatigue, Selank targets anxiety without sedation, DSIP supports deep sleep architecture, and Tesamorelin supports tissue-level GH effects. Together they address multiple degeneration points where stimulants accelerate breakdown.\n\n## What the evidence actually shows\n\nHuman trials for Tesamorelin: Mult","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"Multiple RCTs showed tesamorelin reduced VAT by 15-24% over 6 months in HIV patients with abdominal fat accumulation.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s0","s10"],"source_status":"sourced","why_material":"Provides human data tier for Tesamorelin body composition effects relevant to GH axis repair layer.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c2","text":"Tesamorelin increased IGF-1 and improved lipids without clinically meaningful glucose changes in 52-week extensions.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s0"],"source_status":"sourced","why_material":"Human safety and metabolic outcomes for stimulant load context.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c4","text":"Intranasal Selank reduced anxiety scores in a small human cohort with mild generalized anxiety disorder over 2 weeks.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s21"],"source_status":"sourced","why_material":"Human anxiolytic data for Selank in anxiety layer.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c3","text":"Semax modulates dopamine and BDNF in rat models of stress and hypoxia.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s19"],"source_status":"sourced","why_material":"Preclinical mechanistic support for neural repair layer.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c5","text":"Reddit users report smoother focus and reduced jitter when stacking Semax/Selank with Adderall.","tier":"anecdotal","weight":0.3,"section":"What people say on Reddit","slot":null,"interaction_risk":false,"status":"active","source_ids":["s24"],"source_status":"sourced","why_material":"Anecdotal cross-reference for stimulant context.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/20554713/","title":"Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat","quote":"At wk 26, VAT decreased significantly in tesamorelin-treated patients (-24 +/- 41 vs. 2 +/- 35 cm(2), tesamorelin vs. placebo, P < 0.001...","summary":"Phase III RCT results on VAT reduction and safety.","claim_ids":["c1","c2"],"link_status":"ok","quote_status":"unverified","hash":"ce24a51117760fd34cbefaa3ec8173772ee17ee3801e5003c2b9608d32cdaadc"},{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19243281/","title":"Tesamorelin, a human growth hormone releasing factor analog, in HIV-infected patients with abdominal fat accumulation","quote":"VAT decreased by 10.9% (2.21 cm2) in the tesamorelin 2 mg group vs 0.6% (1 cm2) in the placebo group","summary":"Additional RCT confirming VAT effects.","claim_ids":["c1"],"link_status":"ok","quote_status":"unverified","hash":"886f8b9a7de8f5dd10bb130fc0c54b01ae012b741b30c3495c51e2738a6ee7c8"},{"id":"s19","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16996699/","title":"Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome","quote":"Pretreatment with Semax potentiated the effects of D-amphetamine on the dopaminergic system of the striatum","summary":"Rat study on Semax and amphetamine interactions.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"412fbaa8fcdde45e6273e5ccc6456536ddf6ecedbc3bb20e5c8297d4a9476527"},{"id":"s21","type":"review","url":"https://www.mdpi.com/1422-0067/27/9/3890","title":"Therapeutic Peptides in Aesthetic, Metabolic and Neurological Applications","quote":"In humans, intranasal Selank has been tested in patients with mild generalized anxiety disorder, leading to a significant reduction in anxiety scores after 2 weeks","summary":"Summary of Selank human data.","claim_ids":["c4"],"link_status":"http_403","quote_status":"unverified","hash":"041402d9037daa1b8f0986b98374bb2aff870585c8313826420ce86799042a18"},{"id":"s24","type":"reddit","url":"https://www.reddit.com/r/Biohackers/comments/1t5hr4v/has_anyone_tried_semax_and_selank_stack/","title":"Has anyone tried Semax and Selank Stack?","quote":"Just recently added them to my stack along with DSIP. So far I’ve absolutely noticed better focus / ability to get work done","summary":"User reports on stacking with stimulants.","claim_ids":["c5"],"link_status":"ok","quote_status":"unverified","hash":"f203ab6482d60fd26123d4015489c71d5edfd52d431425cb067e073defe7334d"}],"anecdotal_sources":[{"id":"s24","type":"reddit","url":"https://www.reddit.com/r/Biohackers/comments/1t5hr4v/has_anyone_tried_semax_and_selank_stack/","title":"Has anyone tried Semax and Selank Stack?","quote":"Just recently added them to my stack along with DSIP. So far I’ve absolutely noticed better focus / ability to get work done","summary":"User reports on stacking with stimulants.","claim_ids":["c5"],"link_status":"ok","quote_status":"unverified","hash":"f203ab6482d60fd26123d4015489c71d5edfd52d431425cb067e073defe7334d"}],"scientific_sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/20554713/","title":"Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat","quote":"At wk 26, VAT decreased significantly in tesamorelin-treated patients (-24 +/- 41 vs. 2 +/- 35 cm(2), tesamorelin vs. placebo, P < 0.001...","summary":"Phase III RCT results on VAT reduction and safety.","claim_ids":["c1","c2"],"link_status":"ok","quote_status":"unverified","hash":"ce24a51117760fd34cbefaa3ec8173772ee17ee3801e5003c2b9608d32cdaadc"},{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19243281/","title":"Tesamorelin, a human growth hormone releasing factor analog, in HIV-infected patients with abdominal fat accumulation","quote":"VAT decreased by 10.9% (2.21 cm2) in the tesamorelin 2 mg group vs 0.6% (1 cm2) in the placebo group","summary":"Additional RCT confirming VAT effects.","claim_ids":["c1"],"link_status":"ok","quote_status":"unverified","hash":"886f8b9a7de8f5dd10bb130fc0c54b01ae012b741b30c3495c51e2738a6ee7c8"},{"id":"s19","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16996699/","title":"Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome","quote":"Pretreatment with Semax potentiated the effects of D-amphetamine on the dopaminergic system of the striatum","summary":"Rat study on Semax and amphetamine interactions.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"412fbaa8fcdde45e6273e5ccc6456536ddf6ecedbc3bb20e5c8297d4a9476527"},{"id":"s21","type":"review","url":"https://www.mdpi.com/1422-0067/27/9/3890","title":"Therapeutic Peptides in Aesthetic, Metabolic and Neurological Applications","quote":"In humans, intranasal Selank has been tested in patients with mild generalized anxiety disorder, leading to a significant reduction in anxiety scores after 2 weeks","summary":"Summary of Selank human data.","claim_ids":["c4"],"link_status":"http_403","quote_status":"unverified","hash":"041402d9037daa1b8f0986b98374bb2aff870585c8313826420ce86799042a18"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"tesamorelin-stimulants","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":5,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":5,"claims_total":5,"sources":5,"anecdotal":1,"scientific":4,"user_reports":0,"questions":0,"evidence_ingests":0}}